
|Videos|September 26, 2017
Improving Outcomes in Pancreatic Cancer With Perioperative mFOLFIRINOX
Author(s)Davendra Sohal, MD, MPH
Davendra Sohal, MD, MPH, Department of Hematology and Medical Oncology, Cleveland Clinic, discusses the need for an ongoing study exploring mFOLFIRINOX versus gemcitabine and nab-paclitaxel (Abraxane) in patients with resectable pancreatic adenocarcinoma.




















